| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 81.01× | 81.01× | 75.15× | 84.12× | 100.42× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 1.17× | 1.10× | 2.09× | 3.32× | 3.39× | ||
| 0.68× | 0.68× | 1.25× | 1.39× | 1.13× | ||
| 0.83× | 0.83× | 2.10× | 1.33× | 1.33× | ||
| 10.40× | 10.40× | 1.46× | 0.77× | 0.59× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 100.42 | 84.12 | 75.15 | 81.01 | 81.01 | |
| Working Capital Turnover | 3.39 | 3.32 | 2.09 | 1.10 | 1.17 | |
| Asset Turnover | 1.13 | 1.39 | 1.25 | 0.68 | 0.68 | |
| Cash Conversion (CFO/Net Income) | 1.33 | 1.33 | 2.10 | 0.83 | 0.83 | |
| CFO/EBITDA | 0.59 | 0.77 | 1.46 | 10.40 | 10.40 |